164 related articles for article (PubMed ID: 11810894)
1. Making dollars out of DNA. The first major patent in biotechnology and the commercialization of molecular biology, 1974-1980.
Hughes SS
Isis; 2001 Sep; 92(3):541-75. PubMed ID: 11810894
[TBL] [Abstract][Full Text] [Related]
2. Cohen-Boyer patent to be issued soon.
Sun M
Science; 1984 Apr; 224(4646):264. PubMed ID: 11644123
[TBL] [Abstract][Full Text] [Related]
3. The making of an entrepreneurial science: biotechnology in Britain, 1975-1995.
de Chadarevian S
Isis; 2011 Dec; 102(4):601-33. PubMed ID: 22448540
[TBL] [Abstract][Full Text] [Related]
4. Biotechnology: Cohen-Boyer patent finally confirmed.
Beardsley T
Nature; 1984 Sep 6-11; 311(5981):3. PubMed ID: 6590968
[TBL] [Abstract][Full Text] [Related]
5. Stanford's gene patents hit snags.
Sun M
Science; 1982 Nov; 218(4575):868-9. PubMed ID: 6958066
[TBL] [Abstract][Full Text] [Related]
6. Biotechnology patent challenged: ex-colleague seeks share of the credit.
Budiansky S
Nature; 1982 Nov; 300(5890):303. PubMed ID: 11643831
[TBL] [Abstract][Full Text] [Related]
7. Alienation from the Objectives of the Patent System: How to Remedy the Situation of Biotechnology Patent.
Jiang L
Sci Eng Ethics; 2019 Jun; 25(3):791-811. PubMed ID: 29532279
[TBL] [Abstract][Full Text] [Related]
8. Cohen-Boyer patent: licensees ponder weaknesses.
Budiansky S
Nature; 1984 Dec; 312(5994):487. PubMed ID: 11653583
[TBL] [Abstract][Full Text] [Related]
9. Biotechnology patents: new move confuses US patents world.
Budiansky S
Nature; 1983 Mar; 302(5905):199. PubMed ID: 11653442
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Brazilian biotechnology patent activity from 1975 to 2010.
Dias F; Delfim F; Drummond I; Carmo AO; Barroca TM; Horta CC; Kalapothakis E
Recent Pat DNA Gene Seq; 2012 Aug; 6(2):145-59. PubMed ID: 22670606
[TBL] [Abstract][Full Text] [Related]
11. Intellectual property and biotechnology: the U.S. internal experience--Part I.
Brody B
Kennedy Inst Ethics J; 2006 Mar; 16(1):1-37. PubMed ID: 16770885
[TBL] [Abstract][Full Text] [Related]
12. Biotechnology and its public.
Wade N
Technol Soc; 1984; 6(1):17-21. PubMed ID: 15543682
[TBL] [Abstract][Full Text] [Related]
13. Cancer, viruses, and mass migration: Paul Berg's venture into eukaryotic biology and the advent of recombinant DNA research and technology, 1967-1980.
Yi D
J Hist Biol; 2008; 41(4):589-636. PubMed ID: 19244843
[TBL] [Abstract][Full Text] [Related]
14. Further snag with Stanford patent: filing error claimed in Cohen-Boyer.
Budiansky S
Nature; 1982 Nov; 300(5888):95-6. PubMed ID: 11643815
[TBL] [Abstract][Full Text] [Related]
15. Who owns what? Private ownership and the public interest in recombinant DNA technology in the 1970s.
Yi D
Isis; 2011 Sep; 102(3):446-74. PubMed ID: 22073770
[TBL] [Abstract][Full Text] [Related]
16. Cohen-Boyer patent finally issued.
Norman C
Science; 1984 Sep; 225(4667):1134. PubMed ID: 11653582
[TBL] [Abstract][Full Text] [Related]
17. Rewriting the human prospect.
Weber DO
Healthc Forum J; 1993; 36(5):24-33. PubMed ID: 10130391
[No Abstract] [Full Text] [Related]
18. DNA: template for an economic revolution.
Jackson DA
Ann N Y Acad Sci; 1995 Jun; 758():356-65. PubMed ID: 7625704
[No Abstract] [Full Text] [Related]
19. Reinventing the double helix: a novel and nonobvious reconceptualization of the biotechnology patent.
Demaine LJ; Fellmeth AX
Stanford Law Rev; 2002 Nov; 55(2):303-462. PubMed ID: 12494955
[No Abstract] [Full Text] [Related]
20. Stanford seeks life after Cohen-Boyer patent expires.
Lehrman S
Nature; 1993 Jun; 363(6430):574. PubMed ID: 8510742
[No Abstract] [Full Text] [Related]
[Next] [New Search]
